Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vaxart Inc
(NQ:
VXRT
)
0.8599
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxart Inc
< Previous
1
2
3
4
5
6
7
8
Next >
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
VXRT Stock: Why Redditors Are Betting on a Big Squeeze With Vaxart Today
June 11, 2021
VXRT stock is on the move as the company received some very bullish coverage from an analyst initiating coverage today.
Via
InvestorPlace
Why Vaxart Shares Are Trading Higher Today
June 11, 2021
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 30% ...
Via
Benzinga
Most Active Equity Options For Midday - Friday, June 11
June 11, 2021
Top tickers for midday: AMC, AAPL, TSLA, NIO, NVDA, AMZN, CLOV, SNAP, CLF, GME, PLTR, VXRT, AMD, MO, F, SENS, BAC, MSFT, BB, ET.
Via
Talk Markets
Nasdaq, S&P 500 Eye Weekly Wins as Bond Yields Retreat
June 11, 2021
The 10-year Treasury bond yield fell to a three-month low.
Via
Talk Markets
Topics
Bonds
Stocks
Exposures
Debt Markets
US Equities
46 Stocks Moving In Friday's Mid-Day Session
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...
Via
Benzinga
Why Vaxart Stock Is Skyrocketing Today
June 11, 2021
Investors are cheering an analyst's positive recommendation.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
Why Shares of Vaxart Plummeted 38.6% in May
June 10, 2021
This isn't the first time its coronavirus vaccine pill has disappointed investors.
Via
The Motley Fool
Exposures
COVID-19
Bet on a No-Needle Vaccine Strategy with Vaxart
June 09, 2021
Reimagining Covid-19 vaccines isn't an easy task, but Vaxart is prepared to innovate - and VXRT stock could move higher at any given moment.
Via
InvestorPlace
Exposures
COVID-19
10 More Current & Former Penny Stocks With High Short Interest
June 08, 2021
High Short Interest Stocks Are Something Traders Are On The Hunt For & Here's Another 10
Via
Talk Markets
28 Stocks Moving in Tuesday's Pre-Market Session
June 08, 2021
Gainers Aytu Biopharma, Inc. (NASDAQ: AYTU) rose 37.8% to $7.40 in pre-market trading. Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 23.5% to $3.89 in pre-market trading...
Via
Benzinga
5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street
June 08, 2021
If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns over the next year.
Via
The Motley Fool
Topics
Economy
Exposures
Economy
These Vaccine Latecomers Could Still Win Big. Here's How
June 07, 2021
The key is standing out from the crowd.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
Vaxart’s Compelling Story Will Take a Long Time to Play Out
June 03, 2021
As a company attempting to make oral vaccines, Vaxart has a compelling story. However VXRT stock looks to be many years away from paying off.
Via
InvestorPlace
Exposures
COVID-19
With Fading Covid-19 Infections, Vaxart’s Relevance Is Waning
June 02, 2021
Prior to the vaccination rollout from Vaxart’s competitors, VXRT stock appeared a compelling alternative. That’s no longer the case.
Via
InvestorPlace
Exposures
COVID-19
Speculators Should Consider Buying Vaxart Stock
May 26, 2021
Vaxart's vaccine pill could prove to be effective against the original Covid-19 virus and its new variants, sending VXRT stock sky-high.
Via
InvestorPlace
Exposures
COVID-19
Vaxart Could Still Be a Viable Covid 19 Vaccine Play
May 18, 2021
VXRT stock needs to nail the next few studies of its Covid-19 vaccine candidate and prove its thesis to strengthen its bull case.
Via
InvestorPlace
Exposures
COVID-19
Ocugen or Vaxart: Which Will Take Investors Further?
May 15, 2021
These two high-flying biotechs are vying for the same market.
Via
The Motley Fool
Exposures
COVID-19
High Cash Burn Will Push Vaxart Stock Down To $1 Per Share
May 14, 2021
Failed clinical trials and high cash burn mean Vaxart is headed down to cash per share levels. That suggests VXRT stock is worth just $1.
Via
InvestorPlace
Exposures
COVID-19
It Won’t Take Much for Vaxart Stock to Pop Once Again
May 14, 2021
Vaccine stocks are risky, but Americans nervous about a shot might make the difference for VXRT stock
Via
InvestorPlace
Exposures
COVID-19
Is Vaxart a Buy?
May 12, 2021
Can this troubled coronavirus vaccine developer redeem itself and its investors?
Via
The Motley Fool
Exposures
COVID-19
Vaxart’s No-Shot Vaccine Is a Potential Game Changer
May 11, 2021
VXRT stock is down from its highs, but there's no need to worry, as Vaxart has a unique Covid-19 vaccine and some encouraging clinical data.
Via
InvestorPlace
Exposures
COVID-19
Is Vaccine Maker Vaxart Worth Holding From Here?
May 09, 2021
As with most investment decisions, whether to hold depends on the situation. Here are some things to think about.
Via
The Motley Fool
Exposures
COVID-19
Better Vaccine Stock: Ocugen or Vaxart?
May 07, 2021
Here's how the biotechs compare on several key fronts.
Via
The Motley Fool
Exposures
COVID-19
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 06, 2021
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
May 06, 2021
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology...
Via
Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
May 06, 2021
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related...
Via
Benzinga
Vaxart's Vaccine Candidate Is a Pill, Not a Shot. Does It Matter?
May 06, 2021
If it can reach the market of people that are hesitant to be vaccinated, yes.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.